首页> 中文期刊> 《世界临床病例杂志》 >Antiviral effects of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic mice

Antiviral effects of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic mice

         

摘要

AIM To assess the antiviral effects of hepatitis B virus(HBV)S gene-specific anti-gene locked nucleic acid(LNA)in transgenic mice.METHODS Thirty HBV transgenic mice were acclimatized to laboratory conditions and positive for serum HBV surface antigen(HBsAg)and HBV DNA,were randomly divided into 5 groups(n=7),including negative control(blank control,unrelated sequence control),positive control(lamivudine,anti-sense-LNA),and anti-gene-LNA experimental group.LNA was injected into transgenic mice by tail vein while lamivudine was administered by gavage.Serum HBV DNA and HBsAg levels were determined by fluorescence-based PCR and enzymelinked immune sorbent assay,respectively.HBV S gene expression amounts were assessed by reverse transcription polymerase chain reaction.Positive rates of HBsAg in liver cells were evaluated immunohistochemistry.RESULTS Average rate reductions of HBsAg after treatment on the 3rd,5th,and 7th days were 32.34%,45.96%,and 59.15%,respectively.The inhibitory effect of antigene-LNA on serum HBsAg peaked on day 7,with statistically significant differences compared with pretreatment(0.96±0.18 vs 2.35±0.33,P<0.05)and control values(P<0.05 for all).Average reduction rates of HBV DNA on the 3rd,5th,and 7th days were 38.55%,50.95%,and 62.26%,respectively.This inhibitory effect peaked on the 7th day after treatment with anti-gene-LNA,with statistically significant differences compared with pre-treatment(4.17±1.29 vs 11.05±1.25,P<0.05)and control values(P<0.05 for all).The mRNA levels of the HBV S gene(P<0.05 for all)and rates of HBsAg positive liver cells(P<0.05 for all)were significantly reduced compared with the control groups.Liver and kidney function,and histology showed no abnormalities.CONCLUSION Anti-gene-LNA targeting the S gene of HBV displays strong inhibitory effects on HBV in transgenic mice,providing theoretical and experimental bases for gene therapy in HBV.

著录项

  • 来源
    《世界临床病例杂志》 |2018年第8期|P.183-191|共9页
  • 作者单位

    [1]Department of Medical Laboratory Science;

    the Affiliated Hospital of Youjiang Medical College for Nationalities;

    Baise 533000;

    Guangxi Zhuang Autonomous Region;

    China;

    [1]Department of Medical Laboratory Science;

    the Affiliated Hospital of Youjiang Medical College for Nationalities;

    Baise 533000;

    Guangxi Zhuang Autonomous Region;

    China;

    [1]Department of Medical Laboratory Science;

    the Affiliated Hospital of Youjiang Medical College for Nationalities;

    Baise 533000;

    Guangxi Zhuang Autonomous Region;

    China;

    [1]Department of Medical Laboratory Science;

    the Affiliated Hospital of Youjiang Medical College for Nationalities;

    Baise 533000;

    Guangxi Zhuang Autonomous Region;

    China;

    [1]Department of Medical Laboratory Science;

    the Affiliated Hospital of Youjiang Medical College for Nationalities;

    Baise 533000;

    Guangxi Zhuang Autonomous Region;

    China;

    [2]Department of Hepatobiliary Disease Center;

    Guangxi Clinic Medicine Research;

    Baise 533000;

    Guangxi Zhuang Autonomous Region;

    China;

  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类 医药、卫生;
  • 关键词

    Anti-gene therapy; Hepatitis B virus; Locked nucleic acid; Hepatitis B; Transgenic mice; Anti-sensetherapy;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号